Immunophotonics announces 1st patient dosed in the United States
October 10, 2023 | Company
Immunophotonics, Inc., along with Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as the Principal Investiga...
Read more >Immunophotonics Announces 1st Patient Dosed in Multinational Clinical trial in France
September 21, 2023 | Company
Immunophotonics has announced the recruitment and the dosing of its first patient in France at Hôpital Foch in ...
Read more >Climeworks eyes Kenya project to capture carbon dioxide from air
| Company
Climeworks is exploring the development of a large-scale direct air capture (DAC) project in Kenya to remove and...
Read more >CUTISS launches Series C financing round to advance the development of its personalized skin technology
September 18, 2023 | Company
CUTISS seeks to raise the Series C with the participation of existing and new investors to take its personalized...
Read more >SkyCell forges new partnership with Marken
June 14, 2023 | Company
SkyCell is proud to announce its latest partnership with Marken, the clinical trials logistics subsidiary of UPS...
Read more >Seervision Joins Forces with Q-SYS to Redefine Intelligent Video Collaboration
June 12, 2023 | Company
Seervision announces an agreement to join Q-SYS, a division of QSC LLC. The acquisition by Q-SYS represents an e...
Read more >